Gain Therapeutics' CEO Matthias Alder Issues Letter to Shareholders and Provides Operational Update -January 31, 2024 at 08:01 am EST
BETHESDA, Md., Jan. 31, 2024 -- Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today releases the following letter...
Source: marketscreener.com